Clinical Trial Update: Short Course of Amoxicillin for Erysipelas [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a short course of amoxicillin for erysipelas conducted by Assistance Publique - Hôpitaux de Paris has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erysipelas

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Erysipelas | Phase 4 | Status: TERMINATED